Yujun Cai
Concepts (56)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Cyclic Nucleotide Phosphodiesterases, Type 1 | 3 | 2009 | 9 |
Why?
|
Lysosomes | 1 | 2010 | 38 |
Why?
|
Collagen Type I | 1 | 2010 | 32 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2010 | 59 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2010 | 35 |
Why?
|
Calmodulin | 2 | 2009 | 34 |
Why?
|
Calcium | 2 | 2009 | 208 |
Why?
|
Cyclic Nucleotide-Gated Cation Channels | 1 | 2010 | 5 |
Why?
|
Tissue Culture Techniques | 1 | 2010 | 10 |
Why?
|
Cyclic GMP-Dependent Protein Kinases | 1 | 2010 | 12 |
Why?
|
TCF Transcription Factors | 1 | 2010 | 10 |
Why?
|
Protein Phosphatase 2 | 1 | 2010 | 15 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2010 | 18 |
Why?
|
Adenylate Cyclase | 1 | 2010 | 24 |
Why?
|
Bicarbonates | 1 | 2010 | 40 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2010 | 14 |
Why?
|
RNA Interference | 1 | 2010 | 75 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 62 |
Why?
|
Second Messenger Systems | 1 | 2009 | 19 |
Why?
|
Cells, Cultured | 3 | 2009 | 447 |
Why?
|
beta Catenin | 1 | 2010 | 34 |
Why?
|
Cyclic AMP | 1 | 2010 | 89 |
Why?
|
Cardiomegaly | 1 | 2009 | 36 |
Why?
|
Myocytes, Cardiac | 1 | 2009 | 40 |
Why?
|
Rats | 3 | 2009 | 530 |
Why?
|
Phenotype | 1 | 2010 | 303 |
Why?
|
Topotecan | 1 | 2007 | 3 |
Why?
|
Camptothecin | 1 | 2007 | 6 |
Why?
|
Calcium Signaling | 1 | 2009 | 52 |
Why?
|
Signal Transduction | 1 | 2010 | 313 |
Why?
|
Animals | 4 | 2007 | 1031 |
Why?
|
Humans | 3 | 2007 | 1856 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2010 | 26 |
Why?
|
Isoproterenol | 1 | 2009 | 47 |
Why?
|
Cyclic GMP | 1 | 2009 | 30 |
Why?
|
Cardiotonic Agents | 1 | 2009 | 21 |
Why?
|
Enzyme Activation | 1 | 2010 | 177 |
Why?
|
Heart Ventricles | 1 | 2009 | 86 |
Why?
|
Angiotensin II | 1 | 2009 | 31 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2009 | 104 |
Why?
|
Phosphorylation | 1 | 2010 | 224 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2007 | 6 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2007 | 27 |
Why?
|
HL-60 Cells | 1 | 2007 | 28 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 216 |
Why?
|
Cell Proliferation | 1 | 2010 | 227 |
Why?
|
Mice | 2 | 2007 | 623 |
Why?
|
Transcription, Genetic | 1 | 2010 | 253 |
Why?
|
Rats, Sprague-Dawley | 1 | 2009 | 257 |
Why?
|
DNA Damage | 1 | 2007 | 66 |
Why?
|
Mice, Inbred BALB C | 1 | 2007 | 176 |
Why?
|
Models, Molecular | 1 | 2007 | 102 |
Why?
|
Cell Line, Tumor | 1 | 2007 | 208 |
Why?
|
Apoptosis | 1 | 2007 | 265 |
Why?
|
Male | 1 | 2009 | 1553 |
Why?
|
Female | 1 | 2007 | 1643 |
Why?
|
